Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?-Reference-Cited by-同舟云学术

Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?

Published:2022-08-24 Issue:9 Volume:10 Page:1605
ISSN:2227-9032
Container-title:Healthcare
language:en
Short-container-title:Healthcare

Author:

Giannini Andrea^ORCID,Bogani Giorgio,Vizza Enrico,Chiantera Vito,Laganà Antonio Simone^ORCID,Muzii Ludovico^ORCID,Salerno Maria Giovanna,Caserta Donatella,D’Oria Ottavia^ORCID

Abstract

According to 2020 comprehensive global cancer statistics published by the International Agency for Research on Cancer, gynecologic malignancies accounted overall for 16 [...]

Publisher

MDPI AG

Subject

Health Information Management,Health Informatics,Health Policy,Leadership and Management

Link

https://www.mdpi.com/2227-9032/10/9/1605/pdf

Reference33 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

3. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

4. Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

5. Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Annonaceae acetogenins: A potential treatment for gynecological and breast cancer;Fitoterapia;2024-10

2. Effect of ubiquitin-specific proteinase 43 on ovarian serous adenocarcinoma and its clinical significance;Journal of Obstetrics and Gynaecology;2024-06-25

3. Primary Vaginal Mucinous Adenocarcinoma of Intestinal Type—Clinical, Radiological and Morphological Aspects;Medicina;2024-03-22

4. Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study;International Immunopharmacology;2024-03

5. Cost-effectiveness of tisotumab vedotin as a second- or third-line therapy for cervical cancer;Journal of Gynecologic Oncology;2024